Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults
NCT ID: NCT03615339
Last Updated: 2018-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2015-03-16
2015-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Multi-ingredient Supplement Study: a Randomized Controlled Trial in Men and Women
NCT03525197
RIGHTWHEY - Responders In Gut HealTh Markers Using Fermented WHEY
NCT03844152
Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults
NCT00635739
Whey Protein, Resistance Training, and Changes in Body Composition
NCT01186536
Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults
NCT06573749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Molkosan
Consumption of Molkosan (fermented whey) 20ml to be diluted in 200ml water prior to use twice a day (morning \& evening).
Total duration was 6 weeks.
Molkosan
Twice daily (AM and PM) 20ml of fermented whey concentrate consumed diluted in 200ml water
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Molkosan
Twice daily (AM and PM) 20ml of fermented whey concentrate consumed diluted in 200ml water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18-40 kg/m-2
Exclusion Criteria
* Severe gastrointestinal disorders,
* Kidney disease,
* Thromboembolic or coagulation disease,
* Hepatic disease,
* Alcohol or any other substance abuse
* Gout
* Eating disorders
* Unregulated thyroid disease
* Dairy intolerance
* Antibiotic use within the last 3 months, including prescribed use
* Current prebiotic or prebiotic use
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
A. Vogel
UNKNOWN
University of Aberdeen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra M Johnstone, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Rowett Institute, University of Aberdeen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Rowett Institute, Human Nutrition Unit
Aberdeen, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Smith NM, Maloney NG, Shaw S, Horgan GW, Fyfe C, Martin JC, Suter A, Scott KP, Johnstone AM. Daily Fermented Whey Consumption Alters the Fecal Short-Chain Fatty Acid Profile in Healthy Adults. Front Nutr. 2020 Sep 30;7:165. doi: 10.3389/fnut.2020.00165. eCollection 2020.
Related Links
Access external resources that provide additional context or updates about the study.
A. Vogel product website and description
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
799
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.